Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

Molecular and Cellular Biology

Volumn 20, Issue 2, 2000, Pages 672-683

  Lee, Richard J ^a   Albanese, Chris ^a   Fu, Maofu ^a   D'Amico, Mark ^a   Lin, Bing ^b   Watanabe, Genichi ^a   Haines III, George K ^c   Siegel, Peter M ^d   Hung, Mien Chie ^e   Yarden, Yosef ^f   Horowitz, Jonathan M ^b   Muller, William J ^d   Pestell, Richard G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF TEXAS   (United States)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MONOMERIC GTP-BINDING PROTEINS; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; RNA, ANTISENSE; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 0033961809     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.2.672-683.2000     Document Type: Article

References (83)

1. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
2. Alberts, A. S., O. Geneste, and R. Treisman. 1998. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92:475-487.
3. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
4. Alroy, I., L. Soussan, R. Seger, and Y. Yarden. 1999. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 19:1961-1972.
5. Amundadottir, L. T., and P. Leder. 1998. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16:737-746.
6. Kip1. J. Biol. Chem. 274:20805-20811.
7. Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649-657.
8. Bartkota, J., J. Lukas, H. Muller, D. Lutzhoft, M. Strauss, and J. Bartek. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:351-361.
9. Ben-Levy, R., H. F. Paterson, C. J. Marshall, and Y. Yarden. 1994. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J. 13:3302-3311.
10. Bodrug, S. E., B. J. Warner, M. L. Bath, G. J. Lindeman, A. W. Harris, and J.M. Adams. 1994. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13:2124-2130.
11. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, C. Albanese, R. G. Pestell, and J. E. J. Darnell. 1999. Stat3 as an Oncogene. Cell 98:295-303.
12. Ink4a: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1:421-431.
13. Caceres, A., L. I. Binder, M. R. Payne, P. Bender, L. Rebhun, and O. Steward. 1983. Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies. J. Neurosci. 4:394-410.
14. Chen, X., J. C. Azizkhan, and D. C. Lee. 1992. The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter. Oncogene 7:1805-1815.
15. Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573-583.
16. Clark, G. J., A. D. Cox, S. M. Graham, and C. J. Der. 1995. Biological assays for Ras transformation. Methods Enzymol. 255:395-412.
17. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
18. Dickens, M., J. S. Rogers, J. Cavanagh, A. Raitano, Z. Xia, J. R. Halpern, M. E. Greenberg, C. L. Sawyers, and R. J. Davis. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696.
19. Diehl, J. A., and C. J. Sherr. 1997. A dominant negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation of CDK-activating kinase. Mol. Cell. Biol. 17:7362-7374.
20. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
21. Earp, H. S., T. L. Dawson, X. Li, and H. Yu. 1995. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat. 35:115-132.
22. Flemington, E. K., S. H. Speck, and W. G. J. Kaelin. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914-6918.
23. Galbiati, F., D. Volonte, J. A. Engelman, G. Watanabe, R. Burk, R. G. Pestell, and M. P. Lisanti. 1998. Targeted Down-regulation of caveolin-1 is sufficient to drive cell transformation and activate the p42/p44 MAP kinase cascade. EMBO J. 17:6633-6648.
24. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1996. Activated neu induces rapid tumor progression. J. Biol. Chem. 271:7673-7678.
25. Guy, C. T., M. A. Webster, M. Schaller, T. J. Parson, R. D. Cardiff, and W. J. Muller. 1992. Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578-10582.
26. Hirai, H., and C. Sherr. 1996. Interaction of D-type cyclins with a novel Myb-like transcription factor, DMP1. Mol. Cell. Biol. 16:6457-6467.
27. Janes, P. W., R. J. Daly, A. deFazio, and R. L. Sutherland. 1994. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3601-3608.
28. Jardines, L., M. Weiss, B. Fowble, and M. Greene. 1993. neu (c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology 61:268-282.
29. Joyce, D., B. Bouzahzah, M. Fu, M. D'Amico, C. Albanese, J. Steer, J. U. Klein, R. J. Lee, J. D. Segal, J. K. Westwick, C. J. Der, and R. G. Pestell. 1999. Integration of Rac-dependent regulation of cyclin D1 transcription through an NF-kB-dependent pathway. J. Biol. Chem. 274:25245-25249.
30. Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659-1667.
31. Lacroix, H., J. D. Iglehart, M. A. Skinner, and M. H. Kraus. 1989. Overexpression of erbB-2 or EGF-receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastasis. Oncogene 4:145-151.
32. Lammie, G. A., V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters. 1991. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444.
33. v-src signaling in breast cancer cells. J. Biol. Chem. 274:7341-7350.
34. Li, R., G. J. Hannon, D. Beach, and B. Stillman. 1996. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6:189-199.
35. 1 progression in N1H 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
36. 1 checkpoint. Mol. Cell. Biol. 16:6917-6925.
37. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
38. Matsumura, I., T. Kitamura, H. Wakao, H. Tanaka, K. Hashimoto, C. Albanese, J. Downward, R. G. Pestell, and Y. Kanakura. 1999. Transcriptional regulation of cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:101-111.
39. Miltenyi, S., W. Muller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231-238.
40. Minden, A., A. Lin, F.-X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signalling cascade and c-jun transcriptional activity by the small GTPases RAC and Cdc42Hs. Cell 81:1147-1157.
41. Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. 1988. Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
42. Musgrove, E. A., C. S. Lee, M. F. Buckley, and R. L. Sutherland. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91: 8022-8026.
43. Muthuswamy, S. K., P. M. Siegel, D. L. Dankort, M. A. Webster, and W. J. Muller. 1994. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 14:735-743.
44. Nehls, M. C., M. L. Grapilon, and D. A. Brenner. 1992. NF-I/Sp1 switch elements regulate collagen alpha 1(I) gene expression. DNA Cell. Biol. 11:443-452.
45. Neuman, E., M. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzon, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcription independent of Cdk4 activation. Mol. Cell. Biol. 17:5338-5347.
46. Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and S. A. Reeves. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62-67.
47. Peles, E., and Y. Yarden. 1993. Neu and its ligands: from an oncogene to neural factors. Bioessays 15:815-824.
48. Pietras, R. J., J. Arboleda, D. M. Reese, N. Wongripat, M. D. Pegram, L. Ramos, C. M. German, M. G. Parker, M. X. Sliwkowski, and D. J. Slamon. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446.
49. Pinkas-Kramarski, R., L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B. J. Ratzkin, M. Sela, and Y. Yarden. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15:2452-2467.
50. Proud, C. G. 1996. p70 S6 kinase: an enigma with variations. Trends Biochem. Sci. 21:181-185.
51. Qian, X., W. C. Dougall, Z. Fei, and M. I. Greene. 1995. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation. Oncogene 10:211-219.
52. Qiu, R. G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374:457-459.
53. Qiu, R. G., J. Chen, F. McCormick, and M. Symons. 1995. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781-11785.
54. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
55. Scherer, P. E., R. Y. Lewis, D. Volonte, J. A. Engelman, F. Galbiati, J. Couet, D. S. Kohtz, E. van Donselaar, P. Peters, and M. P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2: caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272:29337-29346.
56. Schuuring, E., E. Verhoeven, W. J. Mooi, and R. J. Michalides. 1992. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361.
57. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
58. Shin, T. H., A. J. Paterson, J. H. 3. Grant, A. A. Meluch, and J. E. Kudlow. 1992. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol. Cell. Biol. 12:3998-4006.
59. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
60. Siebenkotten, G., U. Behrens-Jung, S. Miltenyi, K. Petry, and A. Radbruch. 1998. Employing surface markers for the selection of transfected cells, p. 271-281. In D. Recktenwald and A. Radbruch (ed.). Cell separation methods and applications. Marcel Dekker, New York, N.Y.
61. Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Muller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068-7077.
62. Siegel, P. M., E. D. Ryan, R. D. Cardiff, and W. J. Muller. 1999. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 18:2149-2154.
63. Sif, S., and T. D. Gilmore. 1994. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J. Virol. 68:7131-7138.
64. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
65. Solomon, M. J., P. L. Larsen, and A. Varshavsky. 1988. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937-947.
66. Tao, Y., R. F. Kassatly, W. D. Cress, and J. M. Horowitz. 1997. Subunit composition determines E2F DNA-binding site specificity. Mol. Cell. Biol. 17:6994-7007.
67. Van Aelst, L., and C. D'Souza-Schorey. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322.
68. Wallasch, C., F. U. Weiss, G. Niederfellner, B. Jallal, W. Issing, and A. Ullrich. 1995. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 14:4267-4275.
69. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
70. Watanabe, G., C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell. 1998. Inhibition of cyclin D-kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:3212-3222.
71. Watanabe, G., A. Howe, R. J. Lee, C. Albanese, I.-W. Shu, A. Karnezis, L. Zon, J. Kyriakis, K. Rundell, and R. G. Pestell. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861-12866.
72. Watanabe, G., R. J. Lee, C. Albanese, W. E. Rainey, D. Batlle, and R. G. Pestell. 1996. Angiotensin II (AII) activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271:22570-22577.
73. Weinberg, R. A. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457-459.
74. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
75. Weinstat-Saslow, D., M. J. Merino, R. E. Manrow, J. A. Lawrence, R. F. Bluth, K. D. Wittenbel, J. F. Simpson, D. L. Page, and P. S. Steeg. 1995. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1:1257-1259.
76. Westwick, J. K., Q. T. Lambert, G. J. Clark, M. Symons, L. Van Aelst, R. G. Pestell, and C. J. Der. 1997. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell. Biol. 17:1324-1335.
77. Wymann, M. P., G. Bulgarelli-Leva, M. J. Zvelebil, L. Pirola, B. Vanhaesebroeck, M. D. Waterfield, and G. Panayotou. 1996. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol. 16:1722-1733.
78. Xie, Y., K. Li, and M.-C. Hung. 1995. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Oncogene 10:2409-2413.
79. Xiong, W., R. G. Pestell, and M. R. Rosner. 1997. Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol. Cell. Biol. 17:6585-6597.
80. Xu, G., D. M. Livingston, and W. Krek. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357-1361.
81. Ye, J., R. H. Xu, J. Taylor-Papadimitriou, and P. M. Pitha. 1996. Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of α2-integrin expression in human mammary epithelial cells. Mol. Cell. Biol. 16:6178-6189.
82. KIPI blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17:407-415.
83. Zwijsen, R. M. L., R. Klompmaker, E. B. H. G. M. Wientjens, P. M. P. Kristel, B. van der Burg, and R. J. A. M. Michalides. 1996 Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554-2560.